Commentary: IMRT for head and neck cancer: many chapters left to write.
Allen
Aaron M
AM
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts 02215, USA. AALLEN@LROC.HARVARD.EDU
Tishler
Roy B
RB
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004307:Dose-Response Relationship, Radiation; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D020360:Neoadjuvant Therapy; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects / Q000639:trends; D012062:Relative Biological Effectiveness; D047368:Tumor Burden / Q000528:radiation effects
D000970:Antineoplastic Agents